Quanterix Corporation Related Parties Amount in Cost of Sales
Quanterix Corporation (QTRX) reported Related Parties Amount in Cost of Sales of $39.00 thousand for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-11-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RelatedPartiesAmountInCostOfSales · last filed 2020-11-06
- Quanterix Corporation related parties amount in cost of sales for the quarter ending 2020-09-30 was $39.00K, a 51.25% decline year-over-year.
- Quanterix Corporation related parties amount in cost of sales for the quarter ending 2020-06-30 was $30.00K, a 14.29% decline year-over-year.
- Quanterix Corporation related parties amount in cost of sales for the quarter ending 2020-03-31 was $63.00K, a 80.00% increase year-over-year.
- Quanterix Corporation related parties amount in cost of sales for the quarter ending 2019-12-31 was $84.00K, a 154.55% increase year-over-year.
- Quanterix Corporation related parties amount in cost of sales for fiscal 2019 was $234.00K, a 22.51% increase from fiscal 2018.
- Quanterix Corporation related parties amount in cost of sales for fiscal 2018 was $191.00K, a 18.72% decline from fiscal 2017.
- Quanterix Corporation related parties amount in cost of sales for fiscal 2017 was $235.00K, a 27.02% decline from fiscal 2016.
- Quanterix Corporation related parties amount in cost of sales for fiscal 2016 was $322.00K.
| Period end | Related Parties Amount in Cost of Sales 3 month | Related Parties Amount in Cost of Sales 6 month | Related Parties Amount in Cost of Sales 9 month | Related Parties Amount in Cost of Sales 12 month |
|---|---|---|---|---|
| 2020-09-30 | $39.00K 10-Q · filed 2020-11-06 | $69.00K derived: sum of 2 quarters · filed 2020-11-06 | $116.00K 10-Q · filed 2020-11-06 | $216.00K derived: sum of 4 quarters · filed 2020-11-06 |
| 2020-06-30 | $30.00K 10-Q · filed 2020-08-04 | $57.00K 10-Q · filed 2020-08-04 | $177.00K derived: sum of 3 quarters · filed 2020-08-04 | $257.00K derived: sum of 4 quarters · filed 2020-11-06 |
| 2020-03-31 | $63.00K 10-Q · filed 2020-05-07 | $147.00K derived: sum of 2 quarters · filed 2020-05-07 | $227.00K derived: sum of 3 quarters · filed 2020-11-06 | $262.00K derived: sum of 4 quarters · filed 2020-11-06 |
| 2019-12-31 | $84.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $164.00K derived: sum of 2 quarters · filed 2020-11-06 | $199.00K derived: sum of 3 quarters · filed 2020-11-06 | $234.00K 10-K · filed 2020-03-13 |
| 2019-09-30 | $80.00K 10-Q · filed 2020-11-06 | $115.00K derived: sum of 2 quarters · filed 2020-11-06 | $150.00K 10-Q · filed 2020-11-06 | $183.00K derived: sum of 4 quarters · filed 2020-11-06 |
| 2019-06-30 | $35.00K 10-Q · filed 2020-08-04 | $70.00K 10-Q · filed 2020-08-04 | $103.00K derived: sum of 3 quarters · filed 2020-08-04 | $139.00K derived: sum of 4 quarters · filed 2020-08-04 |
| 2019-03-31 | $35.00K 10-Q · filed 2020-05-07 | $68.00K derived: sum of 2 quarters · filed 2020-05-07 | $104.00K derived: sum of 3 quarters · filed 2020-05-07 | $151.00K derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | $33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $69.00K derived: sum of 2 quarters · filed 2020-03-13 | $116.00K derived: sum of 3 quarters · filed 2020-03-13 | $191.00K 10-K · filed 2020-03-13 |
| 2018-09-30 | $36.00K 10-Q · filed 2019-11-08 | $83.00K derived: sum of 2 quarters · filed 2019-11-08 | $158.00K 10-Q · filed 2019-11-08 | $230.00K derived: sum of 4 quarters · filed 2020-03-13 |
| 2018-06-30 | $47.00K 10-Q · filed 2019-08-06 | $122.00K 10-Q · filed 2019-08-06 | $194.00K derived: sum of 3 quarters · filed 2020-03-13 | $206.00K derived: sum of 4 quarters · filed 2020-03-13 |
| 2018-03-31 | $76.00K 10-Q · filed 2019-05-10 | $147.00K derived: sum of 2 quarters · filed 2020-03-13 | $159.00K derived: sum of 3 quarters · filed 2020-03-13 | $255.00K derived: sum of 4 quarters · filed 2020-03-13 |
| 2017-12-31 | $71.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $83.00K derived: sum of 2 quarters · filed 2020-03-13 | $179.00K derived: sum of 3 quarters · filed 2020-03-13 | $235.00K 10-K · filed 2020-03-13 |
| 2017-09-30 | $12.00K 10-Q · filed 2018-11-07 | $108.00K derived: sum of 2 quarters · filed 2018-11-07 | $164.00K 10-Q · filed 2018-11-07 | |
| 2017-06-30 | $96.00K 10-Q · filed 2018-08-10 | $152.00K 10-Q · filed 2018-08-10 | ||
| 2017-03-31 | $56.00K 10-Q · filed 2018-05-15 | |||
| 2016-12-31 | $322.00K 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |